Semaglutide and tirzepatide may share similarities, but they're entirely different. They are both used to treat type 2 diabetes and can even aid in weight loss. Semaglutide is sold as Ozempic, Wegovy, and Rybelsus, while tirzepatide is sold as Mounjaro and Zepbound. Tirzepatide delivers mostly the same benefits as semaglutide but with more efficacy.
The two active ingredients also share similar side effects, like nausea, vomiting, and abdominal pain. Semaglutide and other GLP-1 RAs are currently involved in over 1,300 lawsuits due to causing gastroparesis, vision loss, or bowel obstruction. If you've used semaglutide before and are suffering from one of these conditions, you might be eligible for a claim.
If you didn't have gastroparesis, vision loss, or bowel obstruction before your semaglutide treatment but are experiencing them now, reach out to us quickly. Our team, with over 35 years of experience, will check if you're eligible for a claim. If you are, we'll put you in touch with an attorney who'll help you through the legal process.